These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25071102)

  • 1. Reply to E. C. Smyth et al.
    Mamon HJ; Tepper JE
    J Clin Oncol; 2014 Sep; 32(27):3082. PubMed ID: 25071102
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to E. C. Smyth et al.
    Hulshof MC; Oppedijk V; van der Gaast A
    J Clin Oncol; 2014 Sep; 32(27):3081-2. PubMed ID: 25071131
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal management of esophageal adenocarcinoma: should we be CROSS?
    Smyth EC; Waddell TS; Cunningham D
    J Clin Oncol; 2014 Sep; 32(27):3080-1. PubMed ID: 25071100
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemoradiation therapy: the whole is more than the sum of the parts.
    Mamon HJ; Tepper JE
    J Clin Oncol; 2014 Feb; 32(5):367-9. PubMed ID: 24419110
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of recurrence patterns in esophageal carcinoma after surgery alone and surgery after neoadjuvant chemoradiotherapy: a secondary analysis of the CROSS study].
    Hautmann MG; Kölbl O
    Strahlenther Onkol; 2014 Jul; 190(7):696-8. PubMed ID: 25061651
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.
    Oppedijk V; van der Gaast A; van Lanschot JJ; van Hagen P; van Os R; van Rij CM; van der Sangen MJ; Beukema JC; Rütten H; Spruit PH; Reinders JG; Richel DJ; van Berge Henegouwen MI; Hulshof MC
    J Clin Oncol; 2014 Feb; 32(5):385-91. PubMed ID: 24419108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
    Cohen DJ; Leichman L
    J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
    Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
    Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New aspects of neoadjuvant therapy of malignant tumors of the upper gastrointestinal tract].
    Mönig SP; Berlth F; Chon SH
    Zentralbl Chir; 2014 Dec; 139(6):569-71. PubMed ID: 25674647
    [No Abstract]   [Full Text] [Related]  

  • 10. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
    Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
    Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for Esophageal Adenocarcinoma.
    Lam KO; Kwong DLW
    Methods Mol Biol; 2018; 1756():19-34. PubMed ID: 29600357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of gastroesophageal junction tumors.
    Fox MP; van Berkel V
    Surg Clin North Am; 2012 Oct; 92(5):1199-212. PubMed ID: 23026278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junction.
    Faron M; Cheugoua-Zanetsie AM; Thirion P; Nankivell M; Winter K; Cunningham D; Van der Gaast A; Law S; Langley R; de Vathaire F; Valmasoni M; Mauer M; Roth J; Gebski V; Burmeister BH; Paoletti X; van Sandick J; Fu J; Ducreux M; Blanchard P; Tierney J; Pignon JP; Michiels S;
    Eur J Cancer; 2021 Nov; 157():278-290. PubMed ID: 34555647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
    Zhang XH; Wang QZ
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
    [No Abstract]   [Full Text] [Related]  

  • 15. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
    Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy.
    Tanaka K; Fujiya M; Ijiri M; Takahashi K; Ando K; Nomura Y; Ueno N; Kashima S; Goto T; Sasajima J; Ito T; Moriichi K; Mizukami Y; Tanabe H; Okumura T
    J Gastrointest Cancer; 2019 Sep; 50(3):617-620. PubMed ID: 29457212
    [No Abstract]   [Full Text] [Related]  

  • 17. Patterns of surveillance following curative intent therapy for gastroesophageal cancer.
    Peixoto RD; Lim HJ; Kim H; Abdullah A; Cheung WY
    J Gastrointest Cancer; 2014 Sep; 45(3):325-33. PubMed ID: 24756830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
    Gronnier C; Piessen G; Mariette C
    J Visc Surg; 2012 Feb; 149(1):e23-33. PubMed ID: 22341763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of response evaluation for resectable esophageal adenocarcinoma - a retrospective cohort study.
    Bachmann R; Bachmann J; Hungbauer A; Schmehl J; Sitzmann G; Königsrainer A; Ladurner R
    Int J Surg; 2014 Oct; 12(10):1025-30. PubMed ID: 25192805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.